Holen Sie sich die Stockscreener-App
21.43
1.61%
0.34
Handel nachbörslich:
21.43
Schlusskurs vom Vortag:
$21.09
Offen:
$21.58
24-Stunden-Volumen:
26,051
Relative Volume:
0.30
Marktkapitalisierung:
$1.33B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-7.5896
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
+0.94%
1M Leistung:
-14.69%
6M Leistung:
+23.37%
1J Leistung:
+17.23%
1-Tages-Spanne:
$21.01
$21.76
1-Wochen-Bereich:
$19.56
$21.76
52-Wochen-Spanne:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Vergleichen Sie PHVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
21.43 | 1.33B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Eingeleitet | Guggenheim | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Eingeleitet | Wedbush | Outperform |
| 2023-08-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Eingeleitet | Bryan Garnier | Buy |
| 2022-09-13 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2022-08-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
When is the best time to exit Pharvaris N.V.2025 Fundamental Recap & AI Driven Stock Reports - Newser
Smart tools for monitoring Pharvaris N.V.’s price action2025 Year in Review & Fast Gain Swing Trade Alerts - Newser
Relative strength of Pharvaris N.V. in sector analysisPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
Can Pharvaris N.V. recover in the next quarterWeekly Trade Report & Capital Efficient Trading Techniques - Newser
Pharvaris stock price target lowered to $52 by Citizens JMP - Investing.com
Tools to monitor Pharvaris N.V. recovery probabilityWeekly Profit Recap & Smart Allocation Stock Tips - Newser
Using portfolio simulators with Pharvaris N.V. includedDaily Upside Movement Prediction With Data - Newser
Understanding Pharvaris N.V.’s price movementLong-Term Allocation Strategy Summary Breakdown - Newser
Is Pharvaris N.V. a Top Dividend Stock to Watch in 2025Entry Confirmation Based on Volatility Analysis - Newser
Using data tools to time your Pharvaris N.V. exitWeekly Chart Watchlist with Trade Guidance - Newser
What Fibonacci levels say about Pharvaris N.V. reboundEntry Zone Watchlist With Momentum Focus - Newser
Pharvaris NV reports results for the quarter ended June 30Earnings Summary - TradingView
Using flow based indicators on Pharvaris N.V.Sector Rotation and Stock Opportunity Analysis - Newser
Can volume confirm reversal in Pharvaris N.V.Free Short Term Buy List With Stop Protection - Newser
Does Pharvaris N.V. show high probability of reboundChart Confirmation Setup with ROI Signals - Newser
Can swing trading help recover from Pharvaris N.V. lossesSwing Entry Insight With Forecast Accuracy - Newser
Analyzing net buyer seller activity in Pharvaris N.V.Free Low Drawdown Real Time Trading Tips - Newser
Pharvaris (PHVS) Projected to Post Earnings on Wednesday - Defense World
Volatility clustering patterns for Pharvaris N.V.Capital Growth Plan for New Investors - Newser
How to integrate Pharvaris N.V. into portfolio analysis toolsPattern Breakout Tracker with Screener Tools - Newser
Does Pharvaris N.V. qualify in momentum factor screeningFree Weekly Chart Analysis With Entry Advice - Newser
Real time alert setup for Pharvaris N.V. performanceSecure Trading Strategy Based on Technical Analysis - Newser
Pharvaris N.V. stock momentum explainedEntry Zone Forecast for Momentum Trading - Newser
New Product Launches: Will They Boost Pharvaris N.V. Stock in 2025Real-Time Equity Price Action Analysis - Newser
How does Pharvaris N.V. compare to its peersRapid Return Stock Portfolio - thegnnews.com
Key resistance and support levels for Pharvaris N.V.Weekly Price Target Forecast and Alerts - Newser
Why Pharvaris N.V. is moving todayHigh Return Idea With Technical Filter - Newser
Why Pharvaris N.V. stock attracts strong analyst attentionFree Daily Profit Focused Stock Screener - Newser
Pharvaris N.V. stock outlook for YEAREntry Timing with Downside Risk Analysis - Newser
Pharvaris N.V. Earnings Report Breakdown: What Investors Should KnowTrade Alert System with Volume Analysis - Newser
Pharvaris (PHVS) Bolsters Balance Sheet With $175 Million Offering but What Will It Fund Next? - simplywall.st
Finanzdaten der Pharvaris Nv-Aktie (PHVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):